12 Best Strong Buy Stocks to Invest in According to Wall Street

Page 9 of 11

3. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)

Analyst Upside: 176.82%

Number of Hedge Fund Holders: 60

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the best strong buy stocks to invest in according to Wall Street. In a report released on September 22, Kristen Kluska from Cantor Fitzgerald reiterated a Buy rating on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) and set a price target of $105.00.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) reported $166 million in total revenue for fiscal Q2 2025, with Crysvita revenue coming up to $120 million and Dojolvi revenue reaching $23 million.

The company reaffirmed its 2025 revenue guidance, with total revenue in the $640 million to $670 million range.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) develops, acquires, and commercializes novel products to treat genetic diseases. Its product portfolio includes Crysvita, Mepsevii, Dojolvi, and Evkeeza. In 2024, the company expanded its business through four products in five indications worldwide.

Page 9 of 11